| 000 | 00757 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250513084740.0 | ||
| 264 | 0 | _c19960301 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMannucci, P M | |
| 245 | 0 | 0 |
_aRisk of inhibitor development after intermediate purity coagulation factor concentrates: is it truly low? _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cSep 1995 |
||
| 300 |
_a997 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aFactor IX _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aFactor VIII _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 74 _gno. 3 _gp. 997 |
|
| 999 |
_c8570400 _d8570400 |
||